electroCore, Inc.
NASDAQ:ECOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
electroCore, Inc.
NASDAQ:ECOR
|
US |
|
T
|
Thai Mitsuwa PCL
SET:TMW
|
TH |
|
D
|
Danaher Corp
F:DAP
|
US |
|
E
|
Electro Optic Systems Holdings Ltd
OTC:EOPSF
|
AU |
|
G
|
Graham Holdings Co
DUS:WPOB
|
US |
|
Travis Perkins PLC
F:LFPB
|
UK |
|
Speedy Hire PLC
F:5HN
|
UK |
|
Tokai Carbon Co Ltd
OTC:TKCBF
|
JP |
|
E
|
Entravision Communications Corp
F:EV9
|
US |
Intrinsic Value
Is ECOR undervalued or overvalued?
See the intrinsic value estimate for electroCore, Inc. and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ECOR looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ECOR’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What electroCore Does
electroCore is a medical device company that sells non-invasive nerve stimulation products. Its main device line uses mild electrical pulses on the neck to stimulate the vagus nerve, which is a signal pathway connected to pain, migraine, and other body functions. The company’s products are used by patients under a doctor’s guidance, and they are designed to offer a drug-free treatment option for certain conditions.
- Headquarters
- United States of America US
- Employees
- 83
- IPO date
- Jun 22, 2018
Revenue & Expenses Breakdown
electroCore, Inc.
Earnings Waterfall
electroCore, Inc.
The intrinsic value for electroCore, Inc. (ECOR) under the Base Case is hidden USD.
Compared with the current market price of 7.45 USD, the stock appears hidden.